These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14706091)

  • 21. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
    Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of antibiotic resistance in Escherichia coli isolates obtained from healthy children in Spain.
    Domínguez E; Zarazaga M; Sáenz Y; Briñas L; Torres C
    Microb Drug Resist; 2002; 8(4):321-7. PubMed ID: 12523629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of fluoroquinolones and fluoroquinolone-resistance genes in the aquatic environment.
    Adachi F; Yamamoto A; Takakura K; Kawahara R
    Sci Total Environ; 2013 Feb; 444():508-14. PubMed ID: 23291652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
    Talon D; Lallemand-De-Conto S; Thouverez M; Bertrand X
    Pathol Biol (Paris); 2004 Mar; 52(2):76-81. PubMed ID: 15001235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of mutations in target genes in septicemia isolates of Escherichia coli and Klebsiella pneumoniae with resistance or reduced susceptibility to ciprofloxacin.
    Fendukly F; Karlsson I; Hanson HS; Kronvall G; Dornbusch K
    APMIS; 2003 Sep; 111(9):857-66. PubMed ID: 14510643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinolone resistance and ornithine decarboxylation activity in lactose-negative Escherichia coli.
    Gomig F; Galvão CW; Freitas DL; Labas L; Etto RM; Esmerino LA; Lima MA; Appel MH; Zanata SM; Steffens MB; Nader HB; Silveira RB
    Braz J Microbiol; 2015; 46(3):753-7. PubMed ID: 26413057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens.
    Chenia HY; Pillay B; Pillay D
    J Antimicrob Chemother; 2006 Dec; 58(6):1274-8. PubMed ID: 17040923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification.
    Mavroidi A; Miriagou V; Liakopoulos A; Tzelepi Ε; Stefos A; Dalekos GN; Petinaki E
    BMC Infect Dis; 2012 Dec; 12():371. PubMed ID: 23259844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
    Smith SP; Manges AR; Riley LW
    Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors and mechanisms of fluoroquinolone resistance in 156 Escherichia coli strains clinically isolated from urinary tract infections.
    Yasufuku T; Shigemura K; Shirakawa T; Nakano Y; Tanaka K; Arakawa S; Kinoshita S; Nishimura K; Kawabata M; Fujisawa M
    Scand J Infect Dis; 2011 Feb; 43(2):83-8. PubMed ID: 20942776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinolone resistance in Escherichia coli from Accra, Ghana.
    Namboodiri SS; Opintan JA; Lijek RS; Newman MJ; Okeke IN
    BMC Microbiol; 2011 Feb; 11():44. PubMed ID: 21352598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates.
    Capilla S; Ruiz J; Goñi P; Castillo J; Rubio MC; Jiménez de Anta MT; Gómez-Lus R; Vila J
    J Antimicrob Chemother; 2004 Jun; 53(6):1068-71. PubMed ID: 15117921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae.
    Ruiz J; Gómez J; Navia MM; Ribera A; Sierra JM; Marco F; Mensa J; Vila J
    Diagn Microbiol Infect Dis; 2002 Apr; 42(4):257-61. PubMed ID: 12007443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations.
    Drago L; Nicola L; Mattina R; De Vecchi E
    BMC Microbiol; 2010 Apr; 10():119. PubMed ID: 20409341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark.
    Cavaco LM; Frimodt-Møller N; Hasman H; Guardabassi L; Nielsen L; Aarestrup FM
    Microb Drug Resist; 2008 Jun; 14(2):163-9. PubMed ID: 18500921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of fluoroquinolone resistance among veterinary isolates of avian Escherichia coli.
    White DG; Piddock LJ; Maurer JJ; Zhao S; Ricci V; Thayer SG
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2897-9. PubMed ID: 10991884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population.
    Mulder M; Kiefte-de Jong JC; Goessens WH; de Visser H; Hofman A; Stricker BH; Verbon A
    J Antimicrob Chemother; 2017 Jan; 72(1):281-289. PubMed ID: 27655855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
    Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
    Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.
    Kumagai Y; Kato JI; Hoshino K; Akasaka T; Sato K; Ikeda H
    Antimicrob Agents Chemother; 1996 Mar; 40(3):710-14. PubMed ID: 8851598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.